In this 1-year follow-up study of 141 patients with RA starting bDMARDs, we found calprotectin to be more strongly associated with US and clinical scores of inflammation than ESR, CRP, S100A12, IL-6 and VEGF. This evidence concerns the gene VEGFA and rheumatoid arthritis.